FindTrial
Sign In

Medical portrayal of the synthetic cannabinoid drug users

Investigation of the clinical features of synthetic cannabinoid drug users

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094082
Enrollment
Unknown
Registered
2024-12-17
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Synthetic cannabinoid drug intoxication, synthetic cannabinoid drug withdrawal syndrome, synthetic cannabinoid substance use disorder, synthetic cannabinoid drug-related psychosis

Interventions

Drug users:NA

Sponsors

Affiliated Kangning Hospital of Ningbo University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients who used synthetic cannabinoids for more than 1 month. Be over 18 years of age. Able to communicate, and to understand the relevant research requirements.

Exclusion criteria

Exclusion criteria: 1.anyone who are not informed consent;

Design outcomes

Primary

MeasureTime frame
positivity of the hair on cannabinoid test;Changes in cerebral blood oxygen signals;Electroencephalogram signal;—

Countries

China

Contacts

Public ContactWenhua Zhou

Affiliated Kangning Hospital of Ningbo University

whzhou@vip.163.com+86 574 87602312

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026